Congenital Hemophilia A or B with Inhibitors and Acquired Hemophilia A
Dr. Steven Kang
This event offers 1.0 CE credit to attendees.
To register for this event please also log onto http://www.programrsvp.com/HEM-1205 and enter required information.
• Inhibitors are a serious complication for patients with hemophilia A and B1
• Up to 33% of patients with severe/moderately severe Hemophilia A develop inhibitors2
• Acquired hemophilia A is life-threatening and can worsen if there’s a delay in diagnosis, which frequently occurs3